Profil bibliographique

Akiko Kada

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

190Publications signalées

1942Citations signalées

3Affiliations récentes

Institutions déclarées

Fujita Health University Fujita Health University Hospital Nagoya Medical Center

Domaines associés

Acute Ischemic Stroke ManagementLung Cancer Treatments and MutationsStroke Rehabilitation and RecoveryLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research

Publications récentes

2026 articleOpenAlex

POSTER: ALL-253: Outcomes of Children With Down Syndrome and B-Cell Acute Lymphoblastic Leukemia Treated With a Reduced-Methotrexate Strategy in JCCG ALL-B12

Shunsuke Yamamoto, Motohiro Kato, Yuka Iijima-Yamashita, Masashi Sanada et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

ALL-253: Outcomes of Children With Down Syndrome and B-Cell Acute Lymphoblastic Leukemia Treated With a Reduced-Methotrexate Strategy in JCCG ALL-B12

Shunsuke Yamamoto, Motohiro Kato, Yuka Iijima-Yamashita, Masashi Sanada et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia

Yasuo Kubota, Yasuhiro Okamoto, Toshihiko Imamura, Akiko Kada et autres

0 citationsLeukemia

Accès ouvert 2026 articleOpenAlex

The national early warning score during unscheduled home visits: retrospective cohort study

Takao Ono, Hiroko Watase, Takuma Ishihara, Akiko Kada et autres

0 citationsBJGP Open

Accès ouvert 2026 articleOpenAlex

Granulocyte–macrophage colony-stimulating factor-containing medium for blastocyst recovery culture: study protocol for a randomized controlled trial (GSET-study)

Kyoko Higuchi, Miki Okabe-Kinoshita, Kayoko Kikuchi, Tomoya Kurokawa et autres

0 citationsTrials

2026 articleOpenAlex

Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph + Acute Lymphoblastic Leukemia: A Phase 2 Single‐Arm Trial, JCCG ALL‐Ph13

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki, Kentaro Ohki et autres

1 citationPediatric Blood & Cancer

2026 articleOpenAlex

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis

Katsuto Takenaka, Tomoki Ito, Norio Komatsu, Hiroki Yamaguchi et autres

0 citationsInternational Journal of Hematology

Accès ouvert 2026 articleOpenAlex

Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial

Takenao Koseki, Masashi Kondo, Hidetsugu Fujigaki, Kayoko Kikuchi et autres

0 citationsJMIR Research Protocols

Accès ouvert 2026 articleOpenAlex

Continuous versus Intermittent Midazolam Sedation in Balloon-Assisted Enteroscopy: A Multicenter Randomized Trial

Yasushi Sakakibara, Tomohiko Mannami, Toshio Kuwai, Takashi Kagaya et autres

0 citationsDigestion

Accès ouvert 2025 articleOpenAlex

Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK ‐Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in Japan

Tetsuya Mori, Akiko Kada, Tomoo Osumi, Daisuke Tomizawa et autres

0 citationsCancer Science

2025 articleOpenAlex

Risk‐Stratified Phase II Clinical Trial for Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in Japan

Kenichi Sakamoto, Ryu Yanagisawa, Rintaro Ono, Takehiko Doi et autres

1 citationPediatric Blood & Cancer

2025 preprintOpenAlex

Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial (Preprint)

Takenao Koseki, Masashi Kondo, Hidetsugu Fujigaki, Kayoko Kikuchi et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.